Physician profile
Mitchell Mcknight
NPI 1770965832
$5,735.31
in general payments reported to CMS, 2019-2025
9 companies · $764 in 2025
The $764 reported for 2025 was more than what 83% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,601 · 2020: $446 · 2021: $1,701 · 2023: $1,161 · 2024: $62.91 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $993 · Travel and Lodging: $616 · Education: $250 · Gift: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $992.64 |
| Travel and Lodging | $616.24 |
| Education | $250.00 |
| Gift | $128.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,566.53 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $1,526.23 | 2019-2021 | |
| Stryker Corporation | $1,233.17 | 2019-2021 | |
| Straumann USA LLC | $665.45 | 2024-2025 | |
| Depuy Synthes Sales INC. | $328.00 | 2020-2021 | |
| Kls-Martin L.P. | $130.46 | 2019-2024 | |
| Ultradent Products INC | $128.49 | 2025 | Opalescence |
| Terumo Bct, INC. | $114.66 | 2019 | |
| Axogen | $42.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Mcknight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.